The Asia Pacific parenteral nutrition market was valued at US$ 861.59 million in 2022 and is expected to reach US$ 1,471.33 million by 2030; it is estimated to record a CAGR of 6.9% from 2022 to 2030.
New Product Developments by Companies Boost Asia Pacific Parenteral Nutrition Market
Companies operating in the parenteral medical nutrition market constantly focus on new product launches, which help them improve their sales. A few of the noteworthy developments in the parenteral nutrition market are mentioned below:
In 2023, Baxter Korea launched Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) fluid for critically ill patients.
In 2023, JW Holdings started exporting Winuf Central 736/1,085ml, a three-chamber total parenteral nutrition (TPN), on a large scale to Mongolia via AsiaPharma LLC, a local pharmaceutical company.
Thus, new product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.
Asia Pacific Parenteral Nutrition Market Overview
China faces a high burden of stomach cancer due to the growing prevalence of H. pylori infection among the people. A study (2021) by the World Health Organization's International Agency for Research on Cancer (IARC) and partner institutions in the UK and China found that H. pylori infection is prevalent in China. Furthermore, H. pylori infection was the prime cause for 62.1% of cardia gastric cancer cases and 78.5% of non-cardia gastric cancer cases among adults over 30 years of age. This study by IARC estimated that ~340,000 cases of gastric cancer due to H. pylori infection occur in China every year. According to Global Burden of Diseases study published in October 2020, stomach cancer was among the top 10 causes of death in 2019. Similarly, according to the latest data from the International Agency for Research on Cancer (IARC), the estimated age-standardized incidence rate for stomach cancer in China is 20.58 per 100,000, and the crude rate is 33.06. As per the same source, the estimated number of new cases (aged 0-74) in 2020 for both sexes was 478,508. Thus, owing to the abovementioned factors, the market for parenteral nutrition is likely to witness remarkable growth in China during the forecast period.
Asia Pacific Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Segmentation
The Asia Pacific parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Asia Pacific is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.
By end user, the Asia Pacific is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific share in 2022.
ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Asia Pacific .
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 861.59 Million |
| Market Size by 2030 | US$ 1,471.33 Million |
| CAGR (2022 - 2030) | 6.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Nutrient Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10. Vifor Pharma Management AG
The Asia Pacific Parenteral Nutrition Market is valued at US$ 861.59 Million in 2022, it is projected to reach US$ 1,471.33 Million by 2030.
As per our report Asia Pacific Parenteral Nutrition Market, the market size is valued at US$ 861.59 Million in 2022, projecting it to reach US$ 1,471.33 Million by 2030. This translates to a CAGR of approximately 6.9% during the forecast period.
The Asia Pacific Parenteral Nutrition Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Parenteral Nutrition Market report:
The Asia Pacific Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Parenteral Nutrition Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Parenteral Nutrition Market
